BioSpace News Archive

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that it is building a new cell therapy manufacturing facility in Framingham, Massachusetts for clinical and commercial production of the Company’s investigational cell therapy product candidates.

Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases, today announced that the company is set to join the small cap Russell 2000® Index and the broad-market Russell 3000® Index at the conclusion of this year’s reconstitution of the Russell stock indexes

Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announced it is expanding its clinical services to include special needs and high-risk patient populations enrolled in Medicare Advantage. TRHC will assist health plans in meeting the Care for Older Adults (COA) program requirements. Starting with a large multi-state health plan, TRHC’s SinfoniaRx ® solution wil

The Guideline Represents a Joint Effort by the American Urological Association, Society of Urologic Oncology and American Society of Radiation Oncology to Provide Care for Advanced Prostate Cancer Patients [25-June-2020] BALTIMORE , June 25, 2020 /PRNewswire/ -- The American Urological Association (AUA), American Society for Radiation Oncology (ASTRO) and Society of U

SLS-007 is Seelos’ Second Gene Therapy Program Targeting Alpha-Synuclein Top-line Data Expected Late 2020/Early 2021

Study Published in JCI Insight sheds light on the importance of using both transcriptomics and genomics for patient tumor interrogation to gain actionable insight CULVER CITY, Calif.--( BUSINESS WIRE )-- NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the publication of a study in JCI Insight , a peer-reviewed journal dedicated to biomedical research from preclinical to clinica

The Republic of Azerbaijan today announced the implementation of several key initiatives as the country regains control over COVID-19 – and as cases begin to increase worldwide. Azerbaijan is one of the least impacted countries in the world.

Neurovation Labs, Inc., a biotechnology company developing the first objective diagnostic and companion treatment for Post-traumatic Stress Disorder (PTSD), today announced that it has been awarded a U.S. Air Force Small Business Innovation Research (SBIR) Phase II contract through AFWERX and Air Force Research Lab (AFRL). This award follow

Maintaining efficient cooling water system performance is vital to protecting assets, complying with safety and environmental regulations and controlling operating costs. To help ensure optimal performance, Nalco Water, an Ecolab company, has introduced Rapid Bio Intelligence, a total aerobic bacteria test kit that radically simplifies

New Ventures Funds , a venture fund targeting investments in companies across healthcare and life sciences, is pleased to announce the IPO of one of its portfolio companies, Royalty Pharma (NASDAQ:RPRX). The company raised $2.18 billion through the sale of 77,681,670 of its Class A ordinary shares priced at $28.00 per share